Financhill
Back

Livento Group, Inc. Vs. Kymera Therapeutics, Inc. Sector Stock Comparison

Sell
41

NUGN
Livento Group, Inc.

Last Price:
$0.0000
Seasonality Move:
0.6%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.60
Seasonality Move:
10.35%
Sell
41
Livento Group, Inc. (NUGN) is a Sell

Is Livento Group, Inc. a Buy, Sell or Hold?

  • The current Livento Group, Inc. [NUGN] share price is $0.0029. The Score for NUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

NUGN Stock Price Chart

What is Livento Group, Inc.'s stock price today?

  • The Livento Group, Inc. share price today is $0.0029
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

NUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: 370356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0023 - 0.0023) Buy
Bollinger Bands (100): (0.0031 - 0.0031) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

NUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Buy
20-day SMA: 0 Buy
50-day SMA: 0 Buy
200-day SMA: 8.31 Sell
8-day EMA: 0 Buy
20-day EMA: 0 Buy
50-day EMA: 0.11 Sell
200-day EMA: 24.29 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Livento Group, Inc. Earnings Growth & NUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Livento Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):